Saltar al contenido
Merck

Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.

ACS chemical neuroscience (2017-06-03)
Shannon N Mostyn, Jane E Carland, Susan Shimmon, Renae M Ryan, Tristan Rawling, Robert J Vandenberg
RESUMEN

It has been demonstrated previously that the endogenous compound N-arachidonyl-glycine inhibits the glycine transporter GlyT2, stimulates glycinergic neurotransmission, and provides analgesia in animal models of neuropathic and inflammatory pain. However, it is a relatively weak inhibitor with an IC

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
trans-Vaccenic acid, ≥99% (capillary GC)